Latest statistics and disclosures from Ulys's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Lexicon Pharmaceuticals, Ceres. These five stock positions account for 100.00% of Ulys's total stock portfolio.
  • Added to shares of these 2 stocks: Lexicon Pharmaceuticals (+$34.79M), Ceres.
  • Started 2 new stock positions in Lexicon Pharmaceuticals, Ceres.
  • Reduced shares in these 2 stocks: LXRX (-$28.43M), Ceres.
  • Sold out of its positions in Ceres, LXRX.
  • As of June 30, 2015, Ulys has $34.79M in assets under management (AUM). Assets under management grew from a total value of $28.44M to $34.79M.
  • Independent of market fluctuations, Ulys was a net buyer by $6.35M worth of stocks in the most recent quarter.

Ulys portfolio companies for June 2015 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
Lexicon Pharmaceuticals 99.98 NEW 4321214 8.05 0.00
Ceres 0.02 NEW 3891 2.06 0.00

Past 13F-HR SEC Filings for Ulys

View All Filings for Ulys